Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors

Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors

US Patent 11639353 · Granted May 2, 2023

Estimated economic value: $877,044,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic PAD4 inhibitors2025
Heterocyclic PAD4 inhibitors2025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of galectin-32025
Small molecule inhibitors of Galectin-32025
Small molecule inhibitors of Galectin-32025
Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors2024
3-substituted propionic acids as αV integrin inhibitors2024
3-substituted propionic acids as αV integrin inhibitors2024
3-substituted propionic acids as αV integrin inhibitors2024